跳至主要内容
临床试验/CTRI/2020/05/025188
CTRI/2020/05/025188尚未招募未知

Comparative evaluation of 0.05% Zoledronate gel as Local drug delivery system in chronic Periodontitis and patients of chronic Periodontitis with type 2 Diabetes Mellitus - A randomised clinical trial.

SCB Dental College and Hospital Cuttack0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Systemically healthy patient (except for well controlled Type 2 DM).
  • 2. Pocket depths >= 5mm measured with UNC 15 probe.
  • 3. Clinical attachment loss >= 4mm measured with UNC 15 probe.
  • 4. Vertical bone loss >= 3mm seen on intraoral periapical radiograph.
  • 5. Patients with well controlled Type 2 Diabetes Mellitus classified based on
  • criteria of American Diabetic Association (ADA) and glycated haemoglobin
  • levels (HbA1C).
  • 6. No history of periodontal therapy in the preceding 6 months.
  • 7. No use of antibiotics in the preceding 6 months.
  • 8. Non smokers

排除标准

  • 1. With known systemic disease (other than type 2 diabetes)
  • 2. With known or suspected allergy to ZLN/ bisphosphonate group.
  • 3. Those on systemic ZLN/Bisphosphonate therapy
  • 4. Individuals with Aggressive periodontitis
  • 5. Use of tobacco in any form and alcohol
  • 6. Immunocompromised individuals
  • 7. Pregnant or lactating females
  • 8. Tooth with hopeless prognosis.
  • 9. Serum creatinine clearance Ë? 35ml/min or in patients with
  • evidence of acute renal impairment.

研究者

发起方
SCB Dental College and Hospital Cuttack

相似试验